As elevated levels of HIF-1α in breast tumors have been associated with metabolic changes in tumor cells, metastasis, and chemotherapy resistance [71], HIF-1α upregulation within the mammary microenvironment prior to tumor formation may contribute to the growth of more aggressive tumors (Figure 1). Here, HIF1A is linked to neoplasm.